Please note that we are adding Zimmer Biomet (ZBH) to Investing Ideas on the short side today.
Our Healthcare sector analyst team (Tom Tobin and Andrew Freedman) will send out a detailed stock report outlining our bear case for ZBH next week.
Takeaway: We are adding Zimmer Biomet to Investing Ideas on the short side.
"Most momentum investors stay invested too long, under-reacting and holding tight after truly bad news finally arrives to break the trend," writes MarketPsych's Richard Peterson.read more
“You wonder why the performance of the hedge fund indices is so horrendous,” says Hedgeye CEO Keith McCullough, “they’re all doing the same thing, after the market moves. You shouldn’t be paid for that.”read more
Tune in to this edition of Sector Spotlight with Healthcare analyst Tom Tobin and Healthcare Policy analyst Emily Evans.read more
If you’re short the stock market today, and your boss asks why is the Nasdaq at an all-time high, here’s the only honest answer: So far, Nasdaq company earnings are up 46% year-over-year.read more